<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1611">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04661462</url>
  </required_header>
  <id_info>
    <org_study_id>20200928-2379</org_study_id>
    <nct_id>NCT04661462</nct_id>
  </id_info>
  <brief_title>Health After Covid-19 in Tyrol</brief_title>
  <official_title>Health After COVID-19 in the European Region Tyrol - South Tyrol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Claudiana Landesfachhochschule</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University Innsbruck</source>
  <brief_summary>
    <textblock>
      The aim of the regional online questionnaire is to better understand the pattern of acute&#xD;
      infection and the time of recovery of various symptoms.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ongoing COVID-19 pandemic considerably increases the demand for healthcare and raises&#xD;
      concerns on longterm disease outcome. Accordingly, to increase the knowledge on recovery from&#xD;
      symptoms of acute infection and longterm health effects, a regional COVID-19 online survey on&#xD;
      the health-status after infection will be performed.&#xD;
&#xD;
      This cross-sectional anonymous online survey is initiated and conducted by an&#xD;
      interdisciplinary study team of the Medical University of Innsbruck, Austria.&#xD;
&#xD;
      For each participant, demographic characteristics (e.g. age, gender, district affiliation,&#xD;
      profession), medical history (presence of comorbidities, medication), diagnosis of COVID-19,&#xD;
      symptoms and their duration, treatments and special conditions will be collected.&#xD;
&#xD;
      The aim of the survey is to better understand the pattern of acute infection and the time of&#xD;
      recovery of various symptoms.&#xD;
&#xD;
      The anonymous online survey is open to individuals after COVID-19 infection (proven by&#xD;
      SARS-Cov-2 positive PCR or antibody test) over the age of 16 and living in Tyrol&#xD;
      (Western-Austria).&#xD;
&#xD;
      The survey takes around 30 minutes to complete.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 30, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Population based data on spectrum and recovery from COVID-19 symptoms</measure>
    <time_frame>two weeks after infection</time_frame>
    <description>Percentage of patients manifesting ongoing symptoms after 2 weeks of infection.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Population based data on spectrum and recovery from COVID-19 symptoms</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Spectrum of symptoms at onset and at end of disease.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Predictors of recovery.</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Identification of symptoms or comorbidities associated with Long-Covid-19.</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>COVID-19</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>online survey</intervention_name>
    <description>We invite volunteers after COVID-19 to participate in an online survey.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        voluntary participation of probands after COVID-19, resident in Tyrol, Austria, with access&#xD;
        to online survey;&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  status post COVID-19 infection, defined by a positive SARS-Cov-2 PCR or antibody test&#xD;
&#xD;
          -  age ≥ 16years&#xD;
&#xD;
          -  resident in Tyrol (Austria)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Judith Löffler-Ragg, MD</last_name>
    <phone>++43-512-504-81413</phone>
    <email>judith.loeffler@i-med.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medizinische Universität Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <state>Tyrol</state>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judith Löffler-Ragg</last_name>
      <phone>+4351250481413</phone>
      <email>judith.loeffler@i-med.ac.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 29, 2020</study_first_submitted>
  <study_first_submitted_qc>December 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2020</study_first_posted>
  <last_update_submitted>December 9, 2020</last_update_submitted>
  <last_update_submitted_qc>December 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>long term sequelae</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

